BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37735592)

  • 1. Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.
    Painter MM; Johnston TS; Lundgreen KA; Santos JJS; Qin JS; Goel RR; Apostolidis SA; Mathew D; Fulmer B; Williams JC; McKeague ML; Pattekar A; Goode A; Nasta S; Baxter AE; Giles JR; Skelly AN; Felley LE; McLaughlin M; Weaver J; ; Kuthuru O; Dougherty J; Adamski S; Long S; Kee M; Clendenin C; da Silva Antunes R; Grifoni A; Weiskopf D; Sette A; Huang AC; Rader DJ; Hensley SE; Bates P; Greenplate AR; Wherry EJ
    Nat Immunol; 2023 Oct; 24(10):1711-1724. PubMed ID: 37735592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies.
    Painter MM; Johnston TS; Lundgreen KA; Santos JJS; Qin JS; Goel RR; Apostolidis SA; Mathew D; Fulmer B; Williams JC; McKeague ML; Pattekar A; Goode A; Nasta S; Baxter AE; Giles JR; Skelly AN; Felley LE; McLaughlin M; Weaver J; ; Kuthuru O; Dougherty J; Adamski S; Long S; Kee M; Clendenin C; da Silva Antunes R; Grifoni A; Weiskopf D; Sette A; Huang AC; Rader DJ; Hensley SE; Bates P; Greenplate AR; Wherry EJ
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults.
    Kared H; Wolf AS; Alirezaylavasani A; Ravussin A; Solum G; Tran TT; Lund-Johansen F; Vaage JT; Nissen-Meyer LS; Nygaard UC; Hungnes O; Robertson AH; Næss LM; Trogstad L; Magnus P; Munthe LA; Mjaaland S
    Nat Commun; 2022 Jul; 13(1):4165. PubMed ID: 35851055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection.
    Curlin ME; Bates TA; Guzman G; Schoen D; McBride SK; Carpenter SD; Tafesse FG
    Med; 2022 Dec; 3(12):827-837.e3. PubMed ID: 36198311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.
    Koutsakos M; Lee WS; Reynaldi A; Tan HX; Gare G; Kinsella P; Liew KC; Taiaroa G; Williamson DA; Kent HE; Stadler E; Cromer D; Khoury DS; Wheatley AK; Juno JA; Davenport MP; Kent SJ
    Immunity; 2022 Jul; 55(7):1316-1326.e4. PubMed ID: 35690062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.
    Koutsakos M; Reynaldi A; Lee WS; Nguyen J; Amarasena T; Taiaroa G; Kinsella P; Liew KC; Tran T; Kent HE; Tan HX; Rowntree LC; Nguyen THO; Thomas PG; Kedzierska K; Petersen J; Rossjohn J; Williamson DA; Khoury D; Davenport MP; Kent SJ; Wheatley AK; Juno JA
    Immunity; 2023 Apr; 56(4):879-892.e4. PubMed ID: 36958334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff.
    Gallichotte EN; Nehring M; Stromberg S; Young MC; Snell A; Daniels J; Pabilonia KL; VandeWoude S; Ehrhart N; Ebel GD
    mSphere; 2022 Aug; 7(4):e0016922. PubMed ID: 35862798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection.
    Jeong HW; Kim SM; Jung MK; Noh JY; Yoo JS; Kim EH; Kim YI; Yu K; Jang SG; Gil J; Casel MA; Rare R; Choi JH; Kim HS; Kim JH; Um J; Kim C; Kim Y; Chin BS; Jung S; Choi JY; Song KH; Kim YD; Park JS; Song JY; Shin EC; Choi YK
    Cell Rep Med; 2022 Oct; 3(10):100764. PubMed ID: 36182684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination.
    Barateau V; Peyrot L; Saade C; Pozzetto B; Brengel-Pesce K; Elsensohn MH; Allatif O; Guibert N; Compagnon C; Mariano N; Chaix J; Djebali S; Fassier JB; Lina B; Lefsihane K; Espi M; Thaunat O; Marvel J; Rosa-Calatrava M; Pizzorno A; Maucort-Boulch D; Henaff L; Saadatian-Elahi M; Vanhems P; Paul S; Walzer T; Trouillet-Assant S; Defrance T
    Sci Transl Med; 2023 Mar; 15(687):eade0550. PubMed ID: 36921035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
    Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
    Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of delta and omicron variants on inactivated SARS-CoV-2 vaccine-induced T cell responses in patients with autoimmune diseases and healthy controls.
    Wang S; Li J; Wang S; Ye Y; Li M; Liu Y; Chen B; Lai Y; Li L; Zhuang L; Peng S; Yang N; Zhang H; Xiao H
    Clin Transl Med; 2023 Jan; 13(1):e1171. PubMed ID: 36639826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccine.
    Wang C; Yang S; Duan L; Du X; Tao J; Wang Y; Yang J; Lv Y; Li J; Zhang C; Wen J; Zhu Y; Chang L; Wang H; Wang Q; Zhao W
    Virol J; 2022 Dec; 19(1):223. PubMed ID: 36550578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections.
    Ahmed MIM; Diepers P; Janke C; Plank M; Eser TM; Rubio-Acero R; Fuchs A; Baranov O; Castelletti N; Kroidl I; Olbrich L; Bauer B; Wang D; Prelog M; Liese JG; Reinkemeyer C; Hoelscher M; Steininger P; Überla K; Wieser A; Geldmacher C
    Front Immunol; 2022; 13():1026473. PubMed ID: 36582222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G.
    Anderson M; Stec M; Gosha A; Mohammad T; Boler M; Tojo Suarez R; Behun D; Landay A; Cloherty G; Moy J
    J Infect Dis; 2022 Nov; 226(11):1934-1942. PubMed ID: 36263799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals.
    Naranbhai V; Nathan A; Kaseke C; Berrios C; Khatri A; Choi S; Getz MA; Tano-Menka R; Ofoman O; Gayton A; Senjobe F; Denis KJS; Lam EC; Garcia-Beltran WF; Balazs AB; Walker BD; Iafrate AJ; Gaiha GD
    medRxiv; 2022 Jan; ():. PubMed ID: 35018386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia.
    Jarisch A; Wiercinska E; Huenecke S; Bremm M; Cappel C; Hauler J; Rettinger E; Soerensen J; Hellstern H; Klusmann JH; Ciesek S; Bonig H; Bader P
    Transplant Cell Ther; 2022 Jul; 28(7):366.e1-366.e7. PubMed ID: 35472554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    Pušnik J; König J; Mai K; Richter E; Zorn J; Proksch H; Schulte B; Alter G; Streeck H
    J Virol; 2022 Aug; 96(15):e0076022. PubMed ID: 35862718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
    Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
    J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.